CASI Pharmaceuticals
CASI
CASI
59 hedge funds and large institutions have $57.2M invested in CASI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 58 → 59 (+1)
0.07% more ownership
Funds ownership: 2.2% → 2.27% (+0.07%)
Holders
59
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$675K | |
| 2 | +$559K | |
| 3 | +$444K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$400K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$244K |
Top Sellers
| 1 | -$76K | |
| 2 | -$61K | |
| 3 | -$50.6K | |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$45.1K |
| 5 |
Goldman Sachs
New York
|
-$43.6K |